Cargando…
Comparative Analysis of Genetically Modified Dendritic Cells and Tumor Cells as Therapeutic Cancer Vaccines
We have directly compared the efficacy of two immunotherapeutic strategies for the treatment of cancer: “vaccination” of tumor-bearing mice with genetically modified dendritic cells (DCs), and vaccination with genetically modified tumor cells. Using several different preexisting tumor models that ma...
Autores principales: | Klein, Christoph, Bueler, Hansruedi, Mulligan, Richard C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193145/ https://www.ncbi.nlm.nih.gov/pubmed/10811863 |
Ejemplares similares
-
Mitochondrial and Autophagic Regulation of Adult Neurogenesis in the Healthy and Diseased Brain
por: Büeler, Hansruedi
Publicado: (2021) -
Loss of PTEN-Induced Kinase 1 Regulates Oncogenic Ras-Driven Tumor Growth By Inhibiting Mitochondrial Fission
por: Zhu, Dantong, et al.
Publicado: (2022) -
Lack of PINK1 alters glia innate immune responses and enhances inflammation-induced, nitric oxide-mediated neuron death
por: Sun, Liuke, et al.
Publicado: (2018) -
Dendritic Cells in HIV/SIV Prophylactic and Therapeutic Vaccination
por: Ko, Eun-Ju, et al.
Publicado: (2019) -
Therapeutic Liposomal Vaccines for Dendritic Cell Activation or Tolerance
por: Nagy, Noémi Anna, et al.
Publicado: (2021)